On June 6, 2022, Mithril Capital Management LLC announced that it has filed a definitive proxy statement with SEC and urged the shareholders of Adagio Therapeutics Inc to vote for its board nominees Tamsin Berry, Marc Elia and Clive A. Meanwell, and declassification proposal, at the annual meeting of shareholders scheduled to be held on June 22, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.35 USD | -5.24% | -23.08% | -40.36% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.36% | 280M | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-1.16% | 21.66B | |
-18.35% | 20.77B | |
-8.26% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- IVVD Stock
- News Invivyd, Inc.
- Mithril Capital Management LLC Solicits Proxies from Shareholders of Adagio Therapeutics Inc